- Home
- RMAX vs RNAC Comparison
RMAX vs RNAC Comparison
Compare RMAX & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMAX | RNAC |
|---|---|---|
| Founded | 1973 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.9M | 240.3M |
| IPO Year | 2013 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RMAX | RNAC |
|---|---|---|
| Price | $10.74 | $8.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $11.40 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 365.5K | 259.8K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $195,929,000.00 | $2,797,000.00 |
| Revenue This Year | $2.62 | N/A |
| Revenue Next Year | $1.24 | N/A |
| P/E Ratio | $18.00 | ★ N/A |
| Revenue Growth | ★ 11.13 | N/A |
| 52 Week Low | $5.46 | $5.60 |
| 52 Week High | $11.81 | $14.56 |
Technical Indicators
Market Signals| Indicator | RMAX | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 53.35 | 43.02 |
| Support Level | $10.37 | $6.04 |
| Resistance Level | $11.61 | $9.27 |
| Average True Range (ATR) | 0.61 | 0.66 |
| MACD | -0.05 | -0.28 |
| Stochastic Oscillator | 42.60 | 11.00 |
Price Performance
Historical ComparisonAbout RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.